NCT06374940

Brief Summary

Objective: The comparison of surgical outcomes conventional hysterectomy and manipulator-assisted hysterectomy Study design: Prospective randomized controlled trial. Allocation to either group occurred via computer-generated random numbers. Sequentially numbered, opaque envelopes were prepared according to randomization. The patients were unaware of whether they would undergo a conventional hysterectomy or manipulator-assisted abdominal hysterectomy for their surgical procedure. The research coordinator unveiled group assignments upon individual patient recruitment by opening the corresponding envelope. Study population: Inclusion criteria were patients aged 40-70 years who underwent hysterectomy for benign gynecological indications. Primary outcomes: (1) Operation Time. Secondary outcomes: (1) Postoperative early pain (Visual Analog Score (VAS) at 6th and 24th hours of the surgery) (2) intraoperative complications, (3) postoperative complications

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 16, 2024

Completed
1 day until next milestone

Study Start

First participant enrolled

April 17, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 19, 2024

Completed
28 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 17, 2024

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 18, 2024

Completed
Last Updated

April 19, 2024

Status Verified

April 1, 2024

Enrollment Period

1 month

First QC Date

April 16, 2024

Last Update Submit

April 16, 2024

Conditions

Keywords

Hysterectomy, Manipulator-assisted abdominal hysterectomy

Outcome Measures

Primary Outcomes (1)

  • Duration of the surgical procedure

    The surgical operative time was defined as the time from incision to completion of wound closure, also known as 'cut-to-close' time. In the manipulator-assisted abdominal hysterectomy group, the time of uterine manipulator placement was added to the operation time

    intraoperative

Secondary Outcomes (4)

  • Postoperative pain at 6th hours

    At the 6th hours after the surgical procedure

  • Postoperative pain at 24th hours

    At the 24th hours after the surgical procedure

  • intraoperative complications

    Intraoperative

  • Postoperative complications

    Postoperative, in the first month of the surgery

Study Arms (2)

conventional abdominal hysterectomy

NO INTERVENTION

The surgical technique of conventional abdominal hysterectomy was described in the literature.

Manipulator-assisted Abdominal Hysterectomy

OTHER

In manipulator-assisted abdominal hysterectomy tecnique, a uterine manipulator (SecuFix ® , Richard Wolf) was inserted into the cervix. Conventional hysterectomy steps were performed until the vaginal colpotomy incision. A circular colpotomy incision was made directly over the manipulator silicone cup using a monopolar cautery set at 30W cutting mode without interfering with the cardinal ligament or sacrouterine ligament. The vaginal cuff was sutured using polyglactin 910 (no:1) as a single layer running suture.

Procedure: Manipulator-assisted Abdominal Hysterectomy

Interventions

Manipulator-assisted Abdominal Hysterectomy

Manipulator-assisted Abdominal Hysterectomy

Eligibility Criteria

Age40 Years - 70 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dr.Lütfi Kırdar City Hospital

Istanbul, 34000, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Genital Diseases, Female

Condition Hierarchy (Ancestors)

Female Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Specialist of obstetrics and gynecology

Study Record Dates

First Submitted

April 16, 2024

First Posted

April 19, 2024

Study Start

April 17, 2024

Primary Completion

May 17, 2024

Study Completion

May 18, 2024

Last Updated

April 19, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will share

Upon request, after the work is published

Shared Documents
CSR
Time Frame
Upon request, after the work is published, 5 years
Access Criteria
Upon request, after the work is published, 5 years

Locations